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1.  Introduction 
The concepts of molecular similarity (1-3) and molecular diversity (4, 5) play 
important roles in modern approaches to computer-aided molecular design.  
Molecular similarity provides the simplest, and most widely used, method for virtual 
screening and underlies the use of clustering methods on chemical databases.  
Molecular diversity analysis provides a range of tools for exploring the extent to 
which a set of molecules spans structural space, and underlies many approaches to 
compound selection and to the design of combinatorial libraries.  Many different 
similarity and diversity methods have been described in the literature, and new 
methods continue to appear.  This raises the question of how one can compare 
different methods, so as to identify the most appropriate method(s) for some particular 
application: this paper provides an overview of the ways in which this can be carried 
out, illustrating such comparisons by, principally, our experience of similarity and 
diversity studies that have been carried out in the Chemoinformatics Research Group 
at the University of Sheffield.   
There are two bases for the comparison of similarity and diversity methods.  It 
is possible to compare the efficiency of methods, i.e., the resources, typically 
computer time and computer memory, necessary for the completion of processing.  
Considerations of efficiency, in particular theoretical analyses of computational 
complexity, are important in that they can serve to identify methods that are unlikely 
to be applicable given the rapidly increasing sizes of current and planned chemical 
datasets.  Here, however, we restrict ourselves to comparing the effectiveness of 
similarity and diversity methods, i.e., the extent to which a method is able to satisfy 
the user’s requirements in terms of identifying similar or diverse sets of compounds.  
More specifically, we focus on evaluation criteria based on the availability of 
bioactivity data for the molecules that are being processed, where the data can either 
be qualitative, i.e., a categorical (usually binary) variable, or quantitative, i.e., a real-
valued variable.  The discussion here considers only the criteria that can be used for 
comparative studies: the reader is referred elsewhere for the results of such studies. 
 
2.  Methods 
2.1.  Molecular Similarity Methods 
2.1.1.  Introduction 
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The basic concept of molecular similarity has many applications (1,2) but we focus 
here on its use for similarity-based virtual screening, which is often referred to as 
similarity searching (3).  Here, a user specifies a target structure that is characterised 
by one or more structural descriptors, and this set is compared with the corresponding 
sets of descriptors for each of the molecules in the database.  These comparisons 
enable the calculation of a measure of similarity, i.e., the degree of structural 
relatedness, between the target structure and each of the database structures, and the 
latter are then sorted into order of decreasing similarity with the target.  The output 
from the search is a ranked list in which the structures that are calculated to be most 
similar to the target structure, the nearest neighbours, are located at the top of the list.  
These neighbours form the initial output of the search and will be those that have the 
greatest probability of being of interest to the user, given an appropriate measure of 
inter-molecular structural similarity.  
 Many different types of similarity measure have been discussed in the 
literature but they generally involve three principal components: the representation 
that is used to characterise the molecules that are being compared; the weighting 
scheme that is used to assign differing degrees of importance to the various 
components of these representations; and the similarity coefficient that is used to 
provide a quantitative measure of the degree of structural relatedness between a pair 
of structural representations.  These three components are closely related and it is 
hence most important that a comparative study should seek to ensure that only one of 
these components is varied at any one time.  For example, only a limited amount of 
information might be gained from a comparison of the effectiveness of similarity 
searching using binary fingerprints (e.g., those produced by the UNITY or Daylight 
software) and the Tanimoto coefficient, with the effectiveness of similarity searching 
using a set of computed physicochemical parameters (e.g., those produced by the 
MOLCONN-Z or DiverseSolutions software), some particular standardisation method 
and the Euclidean distance.  Given an appropriate evaluation criterion (as discussed 
below), one might be able to decide that one of these approaches gave better results 
than the other, but one would not be able to identify the relative contributions of the 
various components of the overall similarity measures that were being studied. 
 The basis for all of the evaluation techniques to be discussed here is what is 
commonly referred to as the similar-property principle, which was first stated 
explicitly by Johnson and Maggiora in their seminal 1990 book (1).  The principle 
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states that structurally-similar molecules are expected to exhibit similar properties.  It 
is clear that there are many exceptions to the principle as stated (6,7), since even a 
small change in the structure of a molecule can bring about a radical change in some 
property; for example, replacement of a small alkyl group by a larger one, e.g., methyl 
replaced by t-butyl, can mean that a molecule is now too large to fit a binding site.  
The principle does, however, provide a general rule of thumb that is very widely 
applicable; indeed, if this were not the case, then it would prove difficult indeed to 
develop meaningful structure-activity relationships of any sort.  If the principle does 
hold for a particular dataset, then the top-ranked molecules (which are often referred 
to as the nearest neighbours) in a similarity search are expected to have properties 
that are related to those of the target structure.  We can hence evaluate the 
effectiveness of a structurally-based similarity procedure by the extent to which the 
similarities resulting from its use mirror similarities in some external property, which 
in the context of this paper we take to be biological activity (but could be any type of 
chemical, biological or physical property).  The next two sections of the paper detail 
the ways in which the principle is applied to the analysis of qualitative and 
quantitative datasets. 
2.1.2.  Use of qualitative data 
In what follows, we shall adopt ideas and terminology from that part of 
computer science that is normally referred to as information retrieval (8-10).  The 
measurement of search effectiveness has played a large part in the development of 
information retrieval (or IR) systems, whose principal aim is to identify as many 
documents as possible that are relevant to a user’s query whilst simultaneously 
minimising the number of non-relevant documents that are retrieved.  It is possible to 
apply many of these measures to the evaluation of chemical retrieval systems, where 
one wishes to identify as many molecules as possible that have the same activity as 
the target structure whilst simultaneously minimising the number of inactive 
molecules that are retrieved.   
The relationship between IR and chemical similarity searching is discussed in 
detail by Edgar et al. (11) who summarise the various effectiveness measures in terms 
of the 2´2 contingency table shown in Table 1.  In this table, it is assumed that a 
search has been carried out resulting in the retrieval of the n nearest neighbours at the 
top of the ranked output.  Assume that these n nearest neighbours include a of the A 
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active molecules in the complete database, which contains a total of N molecules.  
Then the recall, R, is defined to be the fraction of the active molecules that are 
retrieved, i.e.,  
A
aR = , 
and the precision, P, is defined to be the fraction of the retrieved molecules that are 
active, i.e., 
n
aP = . 
A retrieval mechanism should seek to maximise both the recall and the precision of a 
search so that, in the ideal case, a user would be presented with all of the actives in the 
database without any additional inactives: needless to say, this ideal is very rarely 
achieved in practice. 
 It is inconvenient to have to specify two measures, i.e., recall and precision, to 
quantify the effectiveness of a search.  The Merck group have made extensive use of 
the enrichment factor, i.e., the number of actives retrieved relative to the number that 
would have been retrieved if compounds had been picked from the database at 
random (12).  Thus, using the notation of Table 1, the enrichment factor at some 
point, n, in the ranking resulting from a similarity search is given by 
NA
na
/
/ . 
Note that since A/N is a constant, the enrichment is monotonic with precision.  Rather 
than specifying the enrichment at some specific point in the ranking, e.g., the top-
1000 positions, it can alternatively be specified at that point where some specific 
fraction, e.g., 50%, of the actives have been retrieved.  Examples of the use of 
enrichment factors are provided by Sheridan et al. (12) and Gillet et al. (13).   
Alternatively, Güner and Henry (14) have introduced the G-H score, which is 
a weighted average of recall and precision.  The score was originally developed for 
evaluating the effectiveness of 3D database searches but can be applied to the 
evaluation of any sort of search for which qualitative bioactivity data are available.  
Using the previous notation, the G-H score is defined to be 
2
RP ba + , 
 6 
where a and b are weights describing the relative importance of recall and precision.  
The lowerbound for the G-H score is zero; if both weights are set to unity, then the 
score is simply the arithmetic mean of recall and precision, i.e., 
2
RP + . 
Examples of the use of the G-H score are provided by Güner and Henry (15) and by 
Raymond and Willett (16), while Edgar et al. discuss other combined measures that 
can be used for chemical similarity searching (11).   
At least three alternative approaches have been widely used.  First, the 
Sheffield group has generally quoted the mean numbers of active compounds 
identified in some fixed number of the top-ranked nearest neighbours, when averaged 
over a set of searches for bioactive target structures.  An early example of the use of 
this approach is a comparison of 3D similarity measures based on inter-atomic 
distances (17), with Briem and Lessel providing a more recent application in their 
extended comparison of virtual screening methods (18).  The use of a fixed cut-off 
means that this measure is basically a reformulation of precision, which is entirely 
acceptable in the early stages of a discovery programme, when the immediate need is 
to identify additional active molecules; however, the measure takes no account of 
recall, which may be an important factor in a detailed comparative study of the 
behaviour of different similarity measures.  A second, and alternative, ‘leave-one-out’ 
classification approach assumes that the activity of one of the molecules in the 
database, X, is unknown.  A similarity search is carried out using X as the target 
structure and the top-x (where x is odd) nearest neighbours identified.  The activity or 
inactivity of X is then predicted on the basis of a majority vote (hence the requirement 
for an odd number) of the known activities of the selected nearest neighbours.  This 
process is repeated for each of the N molecules in turn (or just the A active molecules 
in many cases), yielding a contingency table of the sort shown in Table 2.  Various 
statistics can be produced from the elements of this table: perhaps the most common 
is Cohen’s kappa statistic (19).  This is defined to be  
E
EO
-
-
1
, 
where O and E are the observed and expected accuracies of classification.  These 
accuracies can be defined in terms of the elements of Table 2 as follows: 
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n
liO += , and 
n
lkljjikiE
2
))(())(( +++++
= . 
There are many variants on this basic idea, such as the weighted kappa described by 
Cohen himself (20) and the Rand statistic (21), which is perhaps the most widely used 
of the measures available for comparing different clusterings of the same set of 
objects. 
Finally, it may be of interest to study the performance of a measure across the 
entire ranking resulting from a similarity search, rather than the performance for some 
fixed number of nearest neighbours.  In this case, the most popular approach is the use 
of a cumulative recall graph, which plots the recall against the number of compounds 
retrieved (i.e., a/A against n using the notation of Table 1).  The best-possible such 
graph would hence be one in which the A relevant documents are at the top of the 
ranking, i.e., at rank-positions 1, 2, 3…A (or at rank-positions, N-A+1, N-A+2, N-
A+3…N in the case of the worst-possible ranking).  The use of such diagrams is 
exemplified by studies of similarity searching using physicochemical descriptors (12) 
and of a range of virtual screening methods for searching agrochemical datasets (22).  
The cumulative recall plot is closely related to the receiver operating characteristic 
(ROC) curves that are widely used in signal detection and classification problems 
(23).  An ROC curve plots the true positives against the false positives for different 
classifications of the same set of objects; this corresponds to plotting a against n-a 
using the notation of Table 1, and thus the shape of an ROC curve tends to the shape 
of a cumulative recall plot when n>>a.  An example of the use of ROC plots in 
chemoinformatics is provided by the work of Cuissart et al. on similarity-based 
methods for the prediction of biodegradability (24).  
2.1.3.  Use of quantitative data 
The similar property principle can also be applied to the analysis of datasets 
for which quantitative bioactivity data are available, most commonly using a simple 
modification of the ‘leave-one-out’ classification approach described above.  Here, 
the predicted property value for the target structure X, P(X), is taken to be the 
arithmetic mean of the observed property values of the selected nearest neighbours.  
This procedure results in the calculation of a P(X) value for each of the N structures in 
a dataset, and an overall figure of merit is then obtained by calculating the product 
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moment correlation coefficient between the sets of N observed and N predicted 
values.  This approach can equally well be applied to the evaluation of clustering 
methods, with the predicted values here being the mean of the other compounds in the 
cluster containing the chosen molecule, X.   
This application of the similar property principle was pioneered by Adamson 
and Bush (25, 26) and has since been very extensively applied.  For example, Willett 
and Winterman used it in one of the first detailed comparisons of measures for 
similarity searching (27) and it also formed the basis for Brown and Martin’s much-
cited comparison of clustering methods and structural descriptors for compound 
selection (28).  
 
2.2. Molecular Diversity Methods   
2.2.1.  Introduction 
 The principal aim of molecular diversity analysis is to identify structurally 
diverse (synonyms are dissimilar, disparate and heterogeneous) sets of compounds 
that can then be tested for bioactivity, the assumption being that a structurally diverse 
set will generate more structure-activity information than will a set of compounds 
identified at random.  The sets of compounds can be selected from an existing 
corporate or public database, or can be the result of a systematic combinatorial library 
design process (4, 5).  
 Many of the comments that were made in Section 3.1.1 regarding similarity 
measures are equally applicable to diversity methods, in that the latter involve 
knowledge of the degree of dissimilarity or distance between pairs, or larger groups, 
of molecules.  Here, however, there is also the need to specify a selection algorithm, 
which uses the computed dissimilarities to identify the final structurally diverse set of 
compounds, and there may also be a diversity index, which quantifies the degree of 
diversity in this set.  It is thus important, as with similarity measures, to isolate the 
effect of the various components of the diversity methods that are being analysed in a 
comparative study.  There have been many such comparisons, e.g., (28-33).  Here, we 
focus on diversity indices since it is these that measure the overall effectiveness of a 
method (in fact, while an index is computed once a selection algorithm has completed 
its task, there are some types of algorithm that seek explicitly to optimise the chosen 
index, so that the current value of the index drives the operation of the selection 
algorithm).  
 9 
Many of the early evaluations of the effectiveness of diversity methods used 
structure-based diversity indices, such as functions of inter-molecular dissimilarities 
in the context of distance-based selection methods or of the numbers of occupied cells 
in partition-based selection methods (4).  A wide range of such indices has been 
reported, as discussed in the excellent review by Waldman et al. (34).  They do, 
however, have the limitation that they quantify diversity in chemical space, whereas 
the principal rationale for molecular diversity methods is to maximise diversity in 
biological space (35), and we hence focus here on indices that take account of 
biological activity.   
2.2.2. General screening programmes  
We have noted the importance of the similar property principle, which would 
imply that a set of compounds exhibiting some degree of structural redundancy, i.e., 
containing molecules that are near neighbours of each other, will also exhibit some 
degree of biological redundancy; a structurally diverse subset, conversely, should 
maximise the number of types of activity exhibited by its constituent molecules.  It 
should thus be possible to compare the effectiveness of different structure-based 
selection methods by the extent to which they result in subsets that exhibit as many as 
possible of the types of activity present in the parent dataset.  Maximising biological 
diversity in this way is the principal aim of general screening programs, which aim to 
select molecules from a database (or design combinatorial libraries for synthesis) that 
exhibit the widest possible range of different types of activity.  An obvious measure 
of the diversity of the resulting compounds is hence the number of types of activity 
exhibited by them.  This can be easily tested using one of the public databases that 
contain both chemical structures and pharmacological activities, such as the MACCS 
Drug Data Report (MDDR, at URL http://www.mdli.com/products/mddr.html) or the 
World Drugs Index (WDI, at URL 
http://www.derwent.com/worlddrugindex/index.html) databases.  Thus, in one of the 
earliest comparative studies of methods for comparing diverse database subsets, 
Snarey et al. compared a range of maximum dissimilarity and sphere exclusion 
methods for dissimilarity-based compound selection by means of the number of 
different types of activity present in subsets chosen from molecules in the WDI 
database (31); this approach has been adopted in several subsequent studies. 
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2.2.3. Focused screening programmes 
In a focused screening programme, the aim is to select molecules from a 
database (or design combinatorial libraries for synthesis) that provide the maximum 
amount of information about the relationships that exist between structural features 
and some specific type of biological activity.  If this data is qualitative in nature, then 
a simple count of the active molecules present will suffice to quantify the degree of 
biological diversity.  However, at least some account must additionally be taken of the 
chemical diversity that is present, to avoid a high level of diversity being ascribed to a 
cluster of highly similar molecules (such as “me too” or “fast follower” compounds in 
a drug database).  An example of this approach is a comparison of binning schemes 
for cell-based compound selection by Bayley and Willett (36) that selected one 
molecule from each cell in a grid (thus ensuring that the selected molecules were 
structurally diverse) and then noted how many of these selected molecules were 
bioactive (thus quantifying the biological diversity).   
Once interest has been focused on some small volume of structural space, 
large numbers of molecules are synthesised and tested (and often re-tested in the case 
of HTS data), and the results of these experiments used to develop a quantitative 
structure-activity relationship (QSAR).  It has for long been claimed that the use of 
diverse sets of compounds will enable more robust QSARs to be developed than can 
be developed using randomly-chosen training sets.  That this is in fact the case has 
been demonstrated recently by Golbraikh and Tropsha (37), and one can hence 
quantify the effectiveness of a compound selection method by the predictive power of 
the QSARs that can be derived from the compounds selected by that method.  
Quantitative bioactivity data also lies at the heart of the neighbourhood behaviour 
approach of Patterson et al. (33), which is analogous to the similar property principle 
but emphasises the absolute differences in descriptor values and in bioactivity values, 
rather than the values themselves.  Specifically the authors state that a meaningful 
descriptor for diversity analysis is one for which “small differences in structure do not 
(often) produce large differences in biology”, and then use this idea to compare a 
wide range of descriptor types by means of a c² analysis; an improved version of this 
analysis is described by Dixon and Merz (38). 
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3.  Notes 
1. The group in Sheffield has over two decades experience of carrying out 
comparative studies of similarity (and, more recently, diversity) methods.  
Perhaps the most importance single piece of advice we can give to those 
wishing to carry out comparable studies is the need to use a range of types of 
data, ideally including both homogeneous and heterogeneous datasets.  Only 
by so doing can one ensure the robustness and general applicability of the 
methods that are being compared.  In particular, one would not wish to 
encourage the situation that pertained for some time in the QSAR literature, 
where a new method was normally developed and tested on a single dataset, 
most commonly the set of steroids (39) first popularised by Cramer et al. (40).   
2. In like vein, we would recommend the use of more than just one evaluation 
measure.  That said, it is our experience that different measures usually agree 
as to the relative merits of different approaches (unless there are only very 
minor differences in effectiveness): even so, it is always worth carrying out 
additional analyses to ensure that one’s results are, indeed, independent of the 
evaluation criterion that has been adopted.  
3. Having criticised the exclusive use of the steroid dataset, it does have the great 
advantage that it provides a simple basis for comparison with previous work, 
and it would be highly desirable if comparable test-sets were available for 
similarity and diversity analyses.  To some extent, this is already happening 
with increasing use being made of the qualitative bioactivity data in the 
MDDR and WDI datasets mentioned previously; two other datasets that can 
be used for this purpose, and which have the advantage that they are available 
for public download, are the cancer and AIDS files produced by the National 
Cancer Institute (at URL http://dtp.nci.nih.gov/). 
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Table 1.  Contingency table describing the output of a search in terms of active 
molecules and molecules retrieved in a similarity search retrieving n molecules. 
 
  Active  
  Yes No  
Retrieved Yes a n-a n 
 No A-a N-n-A+a N-n 
  A N-A N 
 
 
Table 2.  Contingency table describing the output of a search in terms of correctly and 
incorrectly predicted molecules in a classification experiment classifying n molecules. 
 
  Classification  
  Active Inactive  
Truth Active i j i+j 
 Inactive k l k+l 
  i+k j+l n 
 
 
 
